Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AirSculpt TechnologiesAIRS -3.11%72 Debt-to-EBITDA is 13.08 as of Mar. 2026, which is 63% above its 10-year median of 8.02. GuruFocus rates AIRS with a GF Score™ of 72/100 and a GF Value™ of $3.89 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 477 Healthcare Providers & Services companies, AirSculpt Technologies ranks worse than 99.58% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for AirSculpt Technologies's Debt-to-EBITDA or its related term are showing as below:
AIRS'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 3.18 Med: 8.02 Max: 76.77
Current: 76.77
During the past 7 years, the highest Debt-to-EBITDA Ratio of AirSculpt Technologies was 76.77. The lowest was 3.18. And the median was 8.02.
AIRS's Debt-to-EBITDA is ranked worse than 99.58% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 2.22
vs AIRS: 76.77
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
AirSculpt Technologies Debt-to-EBITDA Related Terms
AirSculpt Technologies Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for AirSculpt Technologies's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AIRS vs AUNA, CCRN, SRTA: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, AirSculpt Technologies's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AirSculpt Technologies Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, AirSculpt Technologies's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where AirSculpt Technologies's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
AirSculpt Technologies (AIRS) has a Debt-to-EBITDA of 13.08 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on AirSculpt Technologies. This is 63% above median its historical median of 8.02. Over the past decade, AirSculpt Technologies' Debt-to-EBITDA has ranged from 3.18 to 76.77. According to the industry distribution chart, AirSculpt Technologies ranks #475 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 99.6%.
Is AirSculpt Technologies' Debt-to-EBITDA too high?
AirSculpt Technologies' current Debt-to-EBITDA of 13.08 is 63% above median its 10-year median of 8.02. Over the past 10 years, this metric has ranged from a low of 3.18 to a high of 76.77. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.22. AirSculpt Technologies' value of 13.08 is 489.2% above this industry median. Based on the distribution chart, AirSculpt Technologies ranks #475 out of 477 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, AirSculpt Technologies has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AirSculpt Technologies' Debt-to-EBITDA compare to AUNA and CCRN?
According to the Healthcare Providers & Services industry distribution chart, AirSculpt Technologies ranks #475 out of 477 companies for Debt-to-EBITDA. This places AirSculpt Technologies in the lower half of its industry. The industry median Debt-to-EBITDA is 2.22. AirSculpt Technologies' value of 13.08 is 489.2% above this benchmark. Historically, AirSculpt Technologies' own Debt-to-EBITDA has ranged from 3.18 to 76.77 over the past decade. While the company's 10-year median is 8.02 vs. the industry median of 2.22, AirSculpt Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.22, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AirSculpt Technologies's current Debt-to-EBITDA of 13.08 is 489.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on AirSculpt Technologies. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AirSculpt Technologies's current Debt-to-EBITDA is 13.08, which is 63% above median its own 10-year median of 8.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AirSculpt Technologies stock overvalued right now?
Based on GuruFocus' analysis, AirSculpt Technologies (AIRS) is currently considered Modestly Overvalued. The stock's GF Value™ is $3.89, compared to a current price of $4.68 — trading 20.2% above its estimated fair value. The current Debt-to-EBITDA is 13.08, which is 63% above median its 10-year median of 8.02 and 489.2% above the Healthcare Providers & Services industry median of 2.22. AirSculpt Technologies' overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For AirSculpt Technologies (AIRS), the current Debt-to-EBITDA is 13.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AirSculpt Technologies (AIRS) Overvalued in 2026?
Based on GuruFocus' analysis, AirSculpt Technologies stock appears to be overvalued.
The current stock price of $4.68 is trading 20.2% above its estimated GF Value™ of $3.89.
GuruFocus considers AirSculpt Technologies to be Modestly Overvalued.
Key valuation signals for AIRS:
Debt-to-EBITDA: 13.08 (63% above median its 10-year median of 8.02)
GF Value™: $3.89 vs. price of $4.68 (20.2% above fair value)
Industry Position: 489.2% above the Healthcare Providers & Services median (#475 of 477)
No single metric tells the full story. See the AIRS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
72GF Score
Get the complete analysis for AIRS
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIRS has been successfully added to your 
